Dabur India Ltd
NSE:DABUR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
495.2
667.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dabur India Ltd
Dabur India Ltd
Cash Equivalents
Dabur India Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dabur India Ltd
NSE:DABUR
|
Cash Equivalents
₹66m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-33%
|
|
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
Cash Equivalents
₹896.7m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-16%
|
|
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
Cash Equivalents
₹75.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gillette India Ltd
NSE:GILLETTE
|
Cash Equivalents
₹4.8B
|
CAGR 3-Years
42%
|
CAGR 5-Years
27%
|
CAGR 10-Years
11%
|
|
|
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
Cash Equivalents
₹13.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
|
Procter & Gamble Hygiene and Health Care Ltd
NSE:PGHH
|
Cash Equivalents
₹5.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
Dabur India Ltd
Glance View
Dabur India Ltd., a pioneer in the fast-moving consumer goods (FMCG) sector, has built a robust reputation over the years for its commitment to health, wellness, and natural products. Founded in 1884 by Dr. S.K. Burman, the company began its journey with Ayurvedic remedies and has since evolved into a global powerhouse, offering a diverse portfolio that includes personal care, health supplements, and food items. With a presence in over 100 countries and a strong distribution network, Dabur strategically leverages its rich heritage and expert knowledge in herbal medicine, making it a go-to choice for millions seeking quality products rooted in tradition. The company has consistently shown resilience, adapting to evolving consumer preferences and focusing on innovation to drive growth. For investors, Dabur presents a compelling opportunity due to its strong financial performance, efficient operational model, and robust brand equity. The company has consistently reported impressive revenue growth, backed by a well-balanced mix of traditional and contemporary marketing strategies. Its commitment to sustainability and responsible sourcing also resonates with the growing consumer preference for eco-friendly products. As acknowledged by industry analysts, Dabur's focus on expanding its footprint in emerging markets and its ability to introduce new offerings in high-demand categories, such as health and wellness, position it well for continued success in an increasingly competitive landscape. With a blend of historical significance and forward-looking strategies, Dabur India Ltd. stands as a promising investment in the FMCG sector.
See Also
What is Dabur India Ltd's Cash Equivalents?
Cash Equivalents
66m
INR
Based on the financial report for Sep 30, 2024, Dabur India Ltd's Cash Equivalents amounts to 66m INR.
What is Dabur India Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-33%
Over the last year, the Cash Equivalents growth was -98%. The average annual Cash Equivalents growth rates for Dabur India Ltd have been -79% over the past three years , -48% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet
